Earnings Scheduled For February 7, 2023
Companies Reporting Before The Bell
• BP (NYSE:BP) is likely to report quarterly earnings at $1.67 per share on revenue of $53.79 billion.
Preview: Akoustis Technologies’s Earnings
Akoustis Technologies (NASDAQ:AKTS) is set to give its latest quarterly earnings report on Tuesday, 2023-02-07. Here’s what investors…
Reported Late Thursday, Akoustis Announces Pricing Of $30M Public Offering Of 10,909,091 Shares Of Common Stock At A Price Of $2.75/Share
Akoustis Technologies, Inc. (Nasdaq: AKTS) ("Akoustis" or the "Company"), an integrated device manufacturer of patented bulk acoustic wave ("BAW") high-band radio frequency
Why Jupiter Wellness Shares Are Trading Lower By Around 40%? Here Are Other Stocks Moving In Thursday’s Mid-Day Session
Gainers
Genius Group Limited (NYSE: GNS) jumped 87% to $1.00. Genius Group authorized issue of special dividend and appointed Timothy Murphy to lead Illegal Trading Task Force.
PDS Biotechnology To Rally Around 129%? Here Are 5 Other Price Target Changes For Tuesday
Chardan Capital raised PDS Biotechnology Corporation (NASDAQ:PDSB) price target from $15 to $16. . Chardan Capital analyst Geulah…
Oppenheimer Maintains Outperform on Akoustis Technologies, Lowers Price Target to $7
Oppenheimer analyst Rick Schafer maintains Akoustis Technologies (NASDAQ:AKTS) with a Outperform and lowers the price target from $8 to $7.
Akoustis Registers 198% Revenue Growth In Q1 Aided By Production Ramp Up Across 5G Mobile, Infra, Automotive Markets
Akoustis Technologies, Inc (NASDAQ:AKTS) reported first-quarter FY23 revenue growth of 198% year-on-year to $5.57 million, marginally beating the consensus of…
Earnings Scheduled For November 14, 2022
Companies Reporting Before The Bell
• Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million.
